Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID‐19: a retrospective cohort study
Open Access
- 3 August 2020
- journal article
- letter
- Published by Wiley in Journal of Internal Medicine
- Vol. 289 (3), 434-436
- https://doi.org/10.1111/joim.13162
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumoniaEuropean Journal of Internal Medicine, 2020
- Abnormal pulmonary function in COVID-19 patients at time of hospital dischargeEuropean Respiratory Journal, 2020
- Effective treatment of severe COVID-19 patients with tocilizumabProceedings of the National Academy of Sciences of the United States of America, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Costs of Providing Infusion Therapy for Rheumatoid Arthritis in a Hospital-based Infusion Center SettingClinical Therapeutics, 2017
- Long-term complications of critical careCritical Care Medicine, 2011